COVID-19 in the Fall of 2023—Forgotten but Not Gone-Reference-Cited by-同舟云学术

COVID-19 in the Fall of 2023—Forgotten but Not Gone

Published:2023-10-24 Issue:16 Volume:330 Page:1517
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

del Rio Carlos¹,Malani Preeti N.²³

Affiliation:

1. Division of Infectious Diseases, Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia

2. Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor

3. Deputy Editor, JAMA

Abstract

This Viewpoint addresses the state of COVID-19 as of fall 2023 in the US and summarizes key clinical information for health care professionals and patients.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2809658/jama_del_rio_2023_vp_230126_1697473236.93761.pdf

Reference8 articles.

1. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the Omicron variant and severe disease: a systematic review and meta-regression.;Bobrovitz;Lancet Infect Dis,2023

2. COVID-19 Mortality Update - United States, 2022.;Ahmad;MMWR Morb Mortal Wkly Rep,2023

3. Reducing SARS-CoV-2 in shared indoor air.;Dowell;JAMA,2022

4. Estimates of bivalent mRNA vaccine durability in preventing COVID-19-associated hospitalization and critical illness among adults with and without immunocompromising conditions: VISION Network, September 2022-April 2023.;Link-Gelles;MMWR Morb Mortal Wkly Rep,2023

5. COVID-19 therapeutics for nonhospitalized patients.;Gandhi;JAMA,2022

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the rationales and information environments for early, late, and nonadopters of the COVID-19 vaccine;npj Vaccines;2024-09-14

2. The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS;Respiratory Research;2024-04-01

3. COVID-19 myocarditis;Global Cardiology;2024-03-28

4. Predictors of mortality of hospitalized COVID-19 pneumonia patients in university hospital;The Egyptian Journal of Bronchology;2024-03-26

5. Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan;Frontiers in Immunology;2024-03-18